Relationship Between Rhabdomyolysis and SARS-CoV-2 Disease Severity
- PMID: 38410346
- PMCID: PMC10895313
- DOI: 10.7759/cureus.53029
Relationship Between Rhabdomyolysis and SARS-CoV-2 Disease Severity
Abstract
Background Rhabdomyolysis has historically been associated with viral infections, of which influenza A is the most common. A literature review suggests that up to 1/3 of patients hospitalized with COVID-19 develop acute kidney injury (AKI), and of those, nearly half are admitted to the ICU. AKI complicating COVID-19 infection is attributed to several pathogeneses, including sepsis, direct cytopathic effects on the kidneys, and rhabdomyolysis. Objective We aimed to link COVID-19 infection to the development of rhabdomyolysis via creatine kinase (CK) measurement to assess whether this association increases ICU admission, length of stay (LOS), and mortality. Design and setting In this single-center, retrospective cohort study, we enrolled 984 adult patients with confirmed COVID-19 infection requiring admission to a community hospital between March 2020 and May 2021. Measurements Demographic data, laboratory values, and clinical outcomes were collected. The primary outcome measured was the development of rhabdomyolysis and/or AKI. Secondary outcomes included associations of rhabdomyolysis with ICU admission, length of hospital stay, and mortality, utilizing multivariable logistic regression methods. Results Out of the 984 patients included, 39 met the clinical criteria for rhabdomyolysis (4%). The incidence of rhabdomyolysis was higher in patients with AKI (38.3%) and in those who required ICU admission (53.8%) (p<0.001). There was an insignificant difference in death in this cohort (11 patients, 52.4%, p=0.996). However, the mean LOS in patients who had rhabdomyolysis was 18.2 days versus 9.8 days in patients who did not develop rhabdomyolysis (p<0.001). Conclusion Objectively tracking CK levels in COVID-19-infected patients can assist in diagnosing rhabdomyolysis, identifying AKI etiology, and accordingly making a preliminary prognosis for COVID-19 infection, which could direct physicians to initiate more intensive treatment earlier.
Keywords: covid-19; covid-19 and aki; covid-19 mortality; mortality rate in icu; rhabdomyolysis.
Copyright © 2024, Samardzic et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Rhabdomyolysis in patients with COVID-19: A cause or consequence of acute kidney injury or mortality?Medicine (Baltimore). 2025 May 2;104(18):e42368. doi: 10.1097/MD.0000000000042368. Medicine (Baltimore). 2025. PMID: 40324245 Free PMC article.
-
Rhabdomyolysis and acute kidney injury: creatine kinase as a prognostic marker and validation of the McMahon Score in a 10-year cohort: A retrospective observational evaluation.Eur J Anaesthesiol. 2016 Dec;33(12):906-912. doi: 10.1097/EJA.0000000000000490. Eur J Anaesthesiol. 2016. PMID: 27259093
-
Clinical characteristics and risk factors for severe burns complicated by early acute kidney injury.Burns. 2020 Aug;46(5):1100-1106. doi: 10.1016/j.burns.2019.11.018. Epub 2019 Dec 13. Burns. 2020. PMID: 31839503
-
Acute kidney injury in burn patients admitted to the intensive care unit: a systematic review and meta-analysis.Crit Care. 2020 Jan 2;24(1):2. doi: 10.1186/s13054-019-2710-4. Crit Care. 2020. PMID: 31898523 Free PMC article.
-
An observational study on factors associated with ICU mortality in Covid-19 patients and critical review of the literature.Sci Rep. 2023 May 13;13(1):7804. doi: 10.1038/s41598-023-34613-x. Sci Rep. 2023. PMID: 37179397 Free PMC article. Review.
Cited by
-
Slowly Progressive Rhabdomyolysis Post COVID-19: Insights for Acute Kidney Injury Prediction With Discordant Creatine Kinase and Myoglobin Elevations.Cureus. 2024 Aug 29;16(8):e68145. doi: 10.7759/cureus.68145. eCollection 2024 Aug. Cureus. 2024. PMID: 39347295 Free PMC article.
-
Profound Rhabdomyolysis and Viral Myositis Due to SARS-CoV-2: A Case Report.Cureus. 2024 May 27;16(5):e61172. doi: 10.7759/cureus.61172. eCollection 2024 May. Cureus. 2024. PMID: 38933630 Free PMC article.
-
Development of the Mugla Score: an association-based tool for risk stratification in emergency department patients with rhabdomyolysis.Intern Emerg Med. 2025 Jun 11. doi: 10.1007/s11739-025-04009-y. Online ahead of print. Intern Emerg Med. 2025. PMID: 40500517
References
-
- Global, regional, and national incidence and mortality of COVID-19 in 237 countries and territories, January 2022: a systematic analysis for World Health Organization COVID-19 Dashboard. Kim SY, Yeniova AÖ. Life Cycle. 2022;2
-
- World Health Organization. Weekly Epidemiological Update on COVID-19 - 11 May 2023. 2023. https://www.who.int/publications/m/item/weekly-epidemiological-update-on... pp. 1–20.https://www.who.int/publications/m/item/weekly-epidemiological-update-on...
-
- Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Torres PA, Helmstetter JA, Kaye AM, Kaye AD. https://pubmed.ncbi.nlm.nih.gov/25829882/ Ochsner J. 2015;15:58–69. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous